ParkinsonFranceV1, PascalFrancis, Corpus, bibRecord, 001369

Prognosis with Parkinson's disease in Europe : A collaborative study of population-based cohorts

Identifieur interne : 001369 ( PascalFrancis/Corpus ); précédent : 001368; suivant : 001370

Prognosis with Parkinson's disease in Europe : A collaborative study of population-based cohorts

Auteurs : K. Berger ; M. M. B. Breteler ; C. Helmer ; D. Inzitari ; L. Fratiglioni ; C. Trenkwalder ; A. Hofman ; L. J. Launer

Source :

Neurology [ 0028-3878 ] ; 2000.

RBID : Pascal:00-0326325

Descripteurs français

Pascal (Inist)
- Parkinson maladie, Europe, Institution spécialisée, Mortalité, Etude comparative, Pronostic, Evolution, Epidémiologie, Personne âgée.

English descriptors

KwdEn :
- Comparative study, Elderly, Epidemiology, Europe, Evolution, Mortality, Parkinson disease, Prognosis, Specialized institution.

Abstract

Article abstract-Data are lacking on the prognosis (institutionalization and death) of PD cases identified in population-based studies. Data from five population-based European studies were compared and pooled. Each study used comparable two-step screening methods to identify cases and performed one or more follow-up examinations of their respective participants after defined periods of time. PD was classified on the basis of questionnaire and clinical data. The studies include 16,143 participants (252 with PD). The relative risk (RR) (95% CI) of death associated with PD was 2.3 (1.8 to 3.0). The risk for death in men with PD (RR 3.1 [2.1 to 4.4]) was higher than in women with PD (RR 1.8 [1.2 to 5.1]). The rate of institutionalization varied across studies, increased with age, and was considerably higher in PD cases compared to noncases. Women with PD had a fivefold higher risk to live in a care facility than did men with PD. These data on mortality and rate of institutionalization reflect the high burden of PD in the population.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0028-3878`
A02	`01`			`@0 NEURAI`
A03		`1`		`@0 Neurology`
A05				`@2 54`
A06				`@2 11 @3 SUP5`
A08	`01`	`1`	`ENG`	`@1 Prognosis with Parkinson's disease in Europe : A collaborative study of population-based cohorts`
A09	`01`	`1`	`ENG`	`@1 Frequency and Impact of Neurologic Diseases in the Elderly of Europe`
A11	`01`	`1`		`@1 BERGER (K.)`
A11	`02`	`1`		`@1 BRETELER (M. M. B.)`
A11	`03`	`1`		`@1 HELMER (C.)`
A11	`04`	`1`		`@1 INZITARI (D.)`
A11	`05`	`1`		`@1 FRATIGLIONI (L.)`
A11	`06`	`1`		`@1 TRENKWALDER (C.)`
A11	`07`	`1`		`@1 HOFMAN (A.)`
A11	`08`	`1`		`@1 LAUNER (L. J.)`
A12	`01`	`1`		`@1 LAUNER (Lenore J.) @9 ed.`
A12	`02`	`1`		`@1 HOFMAN (Albert) @9 ed.`
A14	`01`			`@1 Institute of Epidemiology and Social Medicine, University of Muenster @3 DEU @Z 1 aut.`
A14	`02`			`@1 Department of Epidemiology & Biostatistics, Erasmus Medical Center @2 Rotterdam @3 NLD @Z 2 aut. @Z 7 aut. @Z 8 aut.`
A14	`03`			`@1 INSERM U330 @2 Bordeaux @3 FRA @Z 3 aut.`
A14	`04`			`@1 Department of Neurological and Psychiatric Sciences, University of Florence @3 ITA @Z 4 aut.`
A14	`05`			`@1 Division Geriatric Medicine, NEUROTEC, Karolinska Institutet, Stockholm Gerontology Research Center @3 SWE @Z 5 aut.`
A14	`06`			`@1 Max-Planck Institute @2 Munich @3 DEU @Z 6 aut.`
A14	`07`			`@1 Epidemiology, Demography, Biometry Program, National Institute on Aging @2 Bethesda, MD @3 USA @Z 8 aut.`
A15	`01`			`@1 Department of Epidemiology & Biostatistics, Erasmus Medical Center @2 Rotterdam @3 NLD @Z 1 aut. @Z 2 aut.`
A15	`02`			`@1 Epidemiology, Demography, Biometry Program, National Institute on Aging @2 Bethesda, Maryland @3 USA @Z 1 aut.`
A17	`01`	`1`		`@1 Neurologic Diseases in the Elderly Research Group @3 INC`
A20				`@2 S24-S27`
A21				`@1 2000`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 6345 @5 354000088769070060`
A44				`@0 0000 @1 © 2000 INIST-CNRS. All rights reserved.`
A45				`@0 26 ref.`
A47	`01`	`1`		`@0 00-0326325`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Neurology`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 Article abstract-Data are lacking on the prognosis (institutionalization and death) of PD cases identified in population-based studies. Data from five population-based European studies were compared and pooled. Each study used comparable two-step screening methods to identify cases and performed one or more follow-up examinations of their respective participants after defined periods of time. PD was classified on the basis of questionnaire and clinical data. The studies include 16,143 participants (252 with PD). The relative risk (RR) (95% CI) of death associated with PD was 2.3 (1.8 to 3.0). The risk for death in men with PD (RR 3.1 [2.1 to 4.4]) was higher than in women with PD (RR 1.8 [1.2 to 5.1]). The rate of institutionalization varied across studies, increased with age, and was considerably higher in PD cases compared to noncases. Women with PD had a fivefold higher risk to live in a care facility than did men with PD. These data on mortality and rate of institutionalization reflect the high burden of PD in the population.
C02	`01`	`X`		`@0 002B17G`
C03	`01`	`X`	`FRE`	`@0 Parkinson maladie @5 01`
C03	`01`	`X`	`ENG`	`@0 Parkinson disease @5 01`
C03	`01`	`X`	`SPA`	`@0 Parkinson enfermedad @5 01`
C03	`02`	`X`	`FRE`	`@0 Europe @2 NG @5 04`
C03	`02`	`X`	`ENG`	`@0 Europe @2 NG @5 04`
C03	`02`	`X`	`SPA`	`@0 Europa @2 NG @5 04`
C03	`03`	`X`	`FRE`	`@0 Institution spécialisée @5 07`
C03	`03`	`X`	`ENG`	`@0 Specialized institution @5 07`
C03	`03`	`X`	`SPA`	`@0 Institución especializada @5 07`
C03	`04`	`X`	`FRE`	`@0 Mortalité @5 10`
C03	`04`	`X`	`ENG`	`@0 Mortality @5 10`
C03	`04`	`X`	`SPA`	`@0 Mortalidad @5 10`
C03	`05`	`X`	`FRE`	`@0 Etude comparative @5 16`
C03	`05`	`X`	`ENG`	`@0 Comparative study @5 16`
C03	`05`	`X`	`SPA`	`@0 Estudio comparativo @5 16`
C03	`06`	`X`	`FRE`	`@0 Pronostic @5 17`
C03	`06`	`X`	`ENG`	`@0 Prognosis @5 17`
C03	`06`	`X`	`SPA`	`@0 Pronóstico @5 17`
C03	`07`	`X`	`FRE`	`@0 Evolution @5 18`
C03	`07`	`X`	`ENG`	`@0 Evolution @5 18`
C03	`07`	`X`	`SPA`	`@0 Evolución @5 18`
C03	`08`	`X`	`FRE`	`@0 Epidémiologie @5 19`
C03	`08`	`X`	`ENG`	`@0 Epidemiology @5 19`
C03	`08`	`X`	`SPA`	`@0 Epidemiología @5 19`
C03	`09`	`X`	`FRE`	`@0 Personne âgée @5 20`
C03	`09`	`X`	`ENG`	`@0 Elderly @5 20`
C03	`09`	`X`	`SPA`	`@0 Anciano @5 20`
C07	`01`	`X`	`FRE`	`@0 Homme`
C07	`01`	`X`	`ENG`	`@0 Human`
C07	`01`	`X`	`SPA`	`@0 Hombre`
C07	`02`	`X`	`FRE`	`@0 Système nerveux pathologie @5 37`
C07	`02`	`X`	`ENG`	`@0 Nervous system diseases @5 37`
C07	`02`	`X`	`SPA`	`@0 Sistema nervioso patología @5 37`
C07	`03`	`X`	`FRE`	`@0 Système nerveux central pathologie @5 38`
C07	`03`	`X`	`ENG`	`@0 Central nervous system disease @5 38`
C07	`03`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 38`
C07	`04`	`X`	`FRE`	`@0 Encéphale pathologie @5 39`
C07	`04`	`X`	`ENG`	`@0 Cerebral disorder @5 39`
C07	`04`	`X`	`SPA`	`@0 Encéfalo patología @5 39`
C07	`05`	`X`	`FRE`	`@0 Extrapyramidal syndrome @5 40`
C07	`05`	`X`	`ENG`	`@0 Extrapyramidal syndrome @5 40`
C07	`05`	`X`	`SPA`	`@0 Extrapiramidal síndrome @5 40`
C07	`06`	`X`	`FRE`	`@0 Maladie dégénérative @5 41`
C07	`06`	`X`	`ENG`	`@0 Degenerative disease @5 41`
C07	`06`	`X`	`SPA`	`@0 Enfermedad degenerativa @5 41`
C07	`07`	`X`	`FRE`	`@0 Santé publique @5 45`
C07	`07`	`X`	`ENG`	`@0 Public health @5 45`
C07	`07`	`X`	`SPA`	`@0 Salud pública @5 45`
N21				`@1 220`

Format Inist (serveur)

NO :	PASCAL 00-0326325 INIST
ET :	Prognosis with Parkinson's disease in Europe : A collaborative study of population-based cohorts
AU :	BERGER (K.); BRETELER (M. M. B.); HELMER (C.); INZITARI (D.); FRATIGLIONI (L.); TRENKWALDER (C.); HOFMAN (A.); LAUNER (L. J.); LAUNER (Lenore J.); HOFMAN (Albert)
AF :	Institute of Epidemiology and Social Medicine, University of Muenster/Allemagne (1 aut.); Department of Epidemiology & Biostatistics, Erasmus Medical Center/Rotterdam/Pays-Bas (2 aut., 7 aut., 8 aut.); INSERM U330/Bordeaux/France (3 aut.); Department of Neurological and Psychiatric Sciences, University of Florence/Italie (4 aut.); Division Geriatric Medicine, NEUROTEC, Karolinska Institutet, Stockholm Gerontology Research Center/Suède (5 aut.); Max-Planck Institute/Munich/Allemagne (6 aut.); Epidemiology, Demography, Biometry Program, National Institute on Aging/Bethesda, MD/Etats-Unis (8 aut.); Department of Epidemiology & Biostatistics, Erasmus Medical Center/Rotterdam/Pays-Bas (1 aut., 2 aut.); Epidemiology, Demography, Biometry Program, National Institute on Aging/Bethesda, Maryland/Etats-Unis (1 aut.)
DT :	Publication en série; Niveau analytique
SO :	Neurology; ISSN 0028-3878; Coden NEURAI; Etats-Unis; Da. 2000; Vol. 54; No. 11 SUP5; S24-S27; Bibl. 26 ref.
LA :	Anglais
EA :	Article abstract-Data are lacking on the prognosis (institutionalization and death) of PD cases identified in population-based studies. Data from five population-based European studies were compared and pooled. Each study used comparable two-step screening methods to identify cases and performed one or more follow-up examinations of their respective participants after defined periods of time. PD was classified on the basis of questionnaire and clinical data. The studies include 16,143 participants (252 with PD). The relative risk (RR) (95% CI) of death associated with PD was 2.3 (1.8 to 3.0). The risk for death in men with PD (RR 3.1 [2.1 to 4.4]) was higher than in women with PD (RR 1.8 [1.2 to 5.1]). The rate of institutionalization varied across studies, increased with age, and was considerably higher in PD cases compared to noncases. Women with PD had a fivefold higher risk to live in a care facility than did men with PD. These data on mortality and rate of institutionalization reflect the high burden of PD in the population.
CC :	002B17G
FD :	Parkinson maladie; Europe; Institution spécialisée; Mortalité; Etude comparative; Pronostic; Evolution; Epidémiologie; Personne âgée
FG :	Homme; Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative; Santé publique
ED :	Parkinson disease; Europe; Specialized institution; Mortality; Comparative study; Prognosis; Evolution; Epidemiology; Elderly
EG :	Human; Nervous system diseases; Central nervous system disease; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Public health
SD :	Parkinson enfermedad; Europa; Institución especializada; Mortalidad; Estudio comparativo; Pronóstico; Evolución; Epidemiología; Anciano
LO :	INIST-6345.354000088769070060
ID :	00-0326325

Links to Exploration step

Pascal:00-0326325

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Prognosis with Parkinson's disease in Europe : A collaborative study of population-based cohorts</title>
<author><name sortKey="Berger, K" sort="Berger, K" uniqKey="Berger K" first="K." last="Berger">K. Berger</name>
<affiliation><inist:fA14 i1="01"><s1>Institute of Epidemiology and Social Medicine, University of Muenster</s1>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Breteler, M M B" sort="Breteler, M M B" uniqKey="Breteler M" first="M. M. B." last="Breteler">M. M. B. Breteler</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Epidemiology & Biostatistics, Erasmus Medical Center</s1>
<s2>Rotterdam</s2>
<s3>NLD</s3>
<sZ>2 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Helmer, C" sort="Helmer, C" uniqKey="Helmer C" first="C." last="Helmer">C. Helmer</name>
<affiliation><inist:fA14 i1="03"><s1>INSERM U330</s1>
<s2>Bordeaux</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Inzitari, D" sort="Inzitari, D" uniqKey="Inzitari D" first="D." last="Inzitari">D. Inzitari</name>
<affiliation><inist:fA14 i1="04"><s1>Department of Neurological and Psychiatric Sciences, University of Florence</s1>
<s3>ITA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Fratiglioni, L" sort="Fratiglioni, L" uniqKey="Fratiglioni L" first="L." last="Fratiglioni">L. Fratiglioni</name>
<affiliation><inist:fA14 i1="05"><s1>Division Geriatric Medicine, NEUROTEC, Karolinska Institutet, Stockholm Gerontology Research Center</s1>
<s3>SWE</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Trenkwalder, C" sort="Trenkwalder, C" uniqKey="Trenkwalder C" first="C." last="Trenkwalder">C. Trenkwalder</name>
<affiliation><inist:fA14 i1="06"><s1>Max-Planck Institute</s1>
<s2>Munich</s2>
<s3>DEU</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Hofman, A" sort="Hofman, A" uniqKey="Hofman A" first="A." last="Hofman">A. Hofman</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Epidemiology & Biostatistics, Erasmus Medical Center</s1>
<s2>Rotterdam</s2>
<s3>NLD</s3>
<sZ>2 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Launer, L J" sort="Launer, L J" uniqKey="Launer L" first="L. J." last="Launer">L. J. Launer</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Epidemiology & Biostatistics, Erasmus Medical Center</s1>
<s2>Rotterdam</s2>
<s3>NLD</s3>
<sZ>2 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="07"><s1>Epidemiology, Demography, Biometry Program, National Institute on Aging</s1>
<s2>Bethesda, MD</s2>
<s3>USA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">00-0326325</idno>
<date when="2000">2000</date>
<idno type="stanalyst">PASCAL 00-0326325 INIST</idno>
<idno type="RBID">Pascal:00-0326325</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001369</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Prognosis with Parkinson's disease in Europe : A collaborative study of population-based cohorts</title>
<author><name sortKey="Berger, K" sort="Berger, K" uniqKey="Berger K" first="K." last="Berger">K. Berger</name>
<affiliation><inist:fA14 i1="01"><s1>Institute of Epidemiology and Social Medicine, University of Muenster</s1>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Breteler, M M B" sort="Breteler, M M B" uniqKey="Breteler M" first="M. M. B." last="Breteler">M. M. B. Breteler</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Epidemiology & Biostatistics, Erasmus Medical Center</s1>
<s2>Rotterdam</s2>
<s3>NLD</s3>
<sZ>2 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Helmer, C" sort="Helmer, C" uniqKey="Helmer C" first="C." last="Helmer">C. Helmer</name>
<affiliation><inist:fA14 i1="03"><s1>INSERM U330</s1>
<s2>Bordeaux</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Inzitari, D" sort="Inzitari, D" uniqKey="Inzitari D" first="D." last="Inzitari">D. Inzitari</name>
<affiliation><inist:fA14 i1="04"><s1>Department of Neurological and Psychiatric Sciences, University of Florence</s1>
<s3>ITA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Fratiglioni, L" sort="Fratiglioni, L" uniqKey="Fratiglioni L" first="L." last="Fratiglioni">L. Fratiglioni</name>
<affiliation><inist:fA14 i1="05"><s1>Division Geriatric Medicine, NEUROTEC, Karolinska Institutet, Stockholm Gerontology Research Center</s1>
<s3>SWE</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Trenkwalder, C" sort="Trenkwalder, C" uniqKey="Trenkwalder C" first="C." last="Trenkwalder">C. Trenkwalder</name>
<affiliation><inist:fA14 i1="06"><s1>Max-Planck Institute</s1>
<s2>Munich</s2>
<s3>DEU</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Hofman, A" sort="Hofman, A" uniqKey="Hofman A" first="A." last="Hofman">A. Hofman</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Epidemiology & Biostatistics, Erasmus Medical Center</s1>
<s2>Rotterdam</s2>
<s3>NLD</s3>
<sZ>2 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Launer, L J" sort="Launer, L J" uniqKey="Launer L" first="L. J." last="Launer">L. J. Launer</name>
<affiliation><inist:fA14 i1="02"><s1>Department of Epidemiology & Biostatistics, Erasmus Medical Center</s1>
<s2>Rotterdam</s2>
<s3>NLD</s3>
<sZ>2 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="07"><s1>Epidemiology, Demography, Biometry Program, National Institute on Aging</s1>
<s2>Bethesda, MD</s2>
<s3>USA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Neurology</title>
<title level="j" type="abbreviated">Neurology</title>
<idno type="ISSN">0028-3878</idno>
<imprint><date when="2000">2000</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Neurology</title>
<title level="j" type="abbreviated">Neurology</title>
<idno type="ISSN">0028-3878</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Comparative study</term>
<term>Elderly</term>
<term>Epidemiology</term>
<term>Europe</term>
<term>Evolution</term>
<term>Mortality</term>
<term>Parkinson disease</term>
<term>Prognosis</term>
<term>Specialized institution</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Europe</term>
<term>Institution spécialisée</term>
<term>Mortalité</term>
<term>Etude comparative</term>
<term>Pronostic</term>
<term>Evolution</term>
<term>Epidémiologie</term>
<term>Personne âgée</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Article abstract-Data are lacking on the prognosis (institutionalization and death) of PD cases identified in population-based studies. Data from five population-based European studies were compared and pooled. Each study used comparable two-step screening methods to identify cases and performed one or more follow-up examinations of their respective participants after defined periods of time. PD was classified on the basis of questionnaire and clinical data. The studies include 16,143 participants (252 with PD). The relative risk (RR) (95% CI) of death associated with PD was 2.3 (1.8 to 3.0). The risk for death in men with PD (RR 3.1 [2.1 to 4.4]) was higher than in women with PD (RR 1.8 [1.2 to 5.1]). The rate of institutionalization varied across studies, increased with age, and was considerably higher in PD cases compared to noncases. Women with PD had a fivefold higher risk to live in a care facility than did men with PD. These data on mortality and rate of institutionalization reflect the high burden of PD in the population.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0028-3878</s0>
</fA01>
<fA02 i1="01"><s0>NEURAI</s0>
</fA02>
<fA03 i2="1"><s0>Neurology</s0>
</fA03>
<fA05><s2>54</s2>
</fA05>
<fA06><s2>11</s2>
<s3>SUP5</s3>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Prognosis with Parkinson's disease in Europe : A collaborative study of population-based cohorts</s1>
</fA08>
<fA09 i1="01" i2="1" l="ENG"><s1>Frequency and Impact of Neurologic Diseases in the Elderly of Europe</s1>
</fA09>
<fA11 i1="01" i2="1"><s1>BERGER (K.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>BRETELER (M. M. B.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>HELMER (C.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>INZITARI (D.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>FRATIGLIONI (L.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>TRENKWALDER (C.)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>HOFMAN (A.)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>LAUNER (L. J.)</s1>
</fA11>
<fA12 i1="01" i2="1"><s1>LAUNER (Lenore J.)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="02" i2="1"><s1>HOFMAN (Albert)</s1>
<s9>ed.</s9>
</fA12>
<fA14 i1="01"><s1>Institute of Epidemiology and Social Medicine, University of Muenster</s1>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Department of Epidemiology & Biostatistics, Erasmus Medical Center</s1>
<s2>Rotterdam</s2>
<s3>NLD</s3>
<sZ>2 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>INSERM U330</s1>
<s2>Bordeaux</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Department of Neurological and Psychiatric Sciences, University of Florence</s1>
<s3>ITA</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>Division Geriatric Medicine, NEUROTEC, Karolinska Institutet, Stockholm Gerontology Research Center</s1>
<s3>SWE</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="06"><s1>Max-Planck Institute</s1>
<s2>Munich</s2>
<s3>DEU</s3>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="07"><s1>Epidemiology, Demography, Biometry Program, National Institute on Aging</s1>
<s2>Bethesda, MD</s2>
<s3>USA</s3>
<sZ>8 aut.</sZ>
</fA14>
<fA15 i1="01"><s1>Department of Epidemiology & Biostatistics, Erasmus Medical Center</s1>
<s2>Rotterdam</s2>
<s3>NLD</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</fA15>
<fA15 i1="02"><s1>Epidemiology, Demography, Biometry Program, National Institute on Aging</s1>
<s2>Bethesda, Maryland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</fA15>
<fA17 i1="01" i2="1"><s1>Neurologic Diseases in the Elderly Research Group</s1>
<s3>INC</s3>
</fA17>
<fA20><s2>S24-S27</s2>
</fA20>
<fA21><s1>2000</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>6345</s2>
<s5>354000088769070060</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2000 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>26 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>00-0326325</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Neurology</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Article abstract-Data are lacking on the prognosis (institutionalization and death) of PD cases identified in population-based studies. Data from five population-based European studies were compared and pooled. Each study used comparable two-step screening methods to identify cases and performed one or more follow-up examinations of their respective participants after defined periods of time. PD was classified on the basis of questionnaire and clinical data. The studies include 16,143 participants (252 with PD). The relative risk (RR) (95% CI) of death associated with PD was 2.3 (1.8 to 3.0). The risk for death in men with PD (RR 3.1 [2.1 to 4.4]) was higher than in women with PD (RR 1.8 [1.2 to 5.1]). The rate of institutionalization varied across studies, increased with age, and was considerably higher in PD cases compared to noncases. Women with PD had a fivefold higher risk to live in a care facility than did men with PD. These data on mortality and rate of institutionalization reflect the high burden of PD in the population.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Parkinson maladie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Europe</s0>
<s2>NG</s2>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Europe</s0>
<s2>NG</s2>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Europa</s0>
<s2>NG</s2>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Institution spécialisée</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Specialized institution</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Institución especializada</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Mortalité</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Mortality</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Mortalidad</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Etude comparative</s0>
<s5>16</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Comparative study</s0>
<s5>16</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Estudio comparativo</s0>
<s5>16</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Pronostic</s0>
<s5>17</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Prognosis</s0>
<s5>17</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Pronóstico</s0>
<s5>17</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Evolution</s0>
<s5>18</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Evolution</s0>
<s5>18</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Evolución</s0>
<s5>18</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Epidémiologie</s0>
<s5>19</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Epidemiology</s0>
<s5>19</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Epidemiología</s0>
<s5>19</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Personne âgée</s0>
<s5>20</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Elderly</s0>
<s5>20</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Anciano</s0>
<s5>20</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Homme</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Human</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Hombre</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>41</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Santé publique</s0>
<s5>45</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Public health</s0>
<s5>45</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Salud pública</s0>
<s5>45</s5>
</fC07>
<fN21><s1>220</s1>
</fN21>
</pA>
</standard>
<server><NO>PASCAL 00-0326325 INIST</NO>
<ET>Prognosis with Parkinson's disease in Europe : A collaborative study of population-based cohorts</ET>
<AU>BERGER (K.); BRETELER (M. M. B.); HELMER (C.); INZITARI (D.); FRATIGLIONI (L.); TRENKWALDER (C.); HOFMAN (A.); LAUNER (L. J.); LAUNER (Lenore J.); HOFMAN (Albert)</AU>
<AF>Institute of Epidemiology and Social Medicine, University of Muenster/Allemagne (1 aut.); Department of Epidemiology & Biostatistics, Erasmus Medical Center/Rotterdam/Pays-Bas (2 aut., 7 aut., 8 aut.); INSERM U330/Bordeaux/France (3 aut.); Department of Neurological and Psychiatric Sciences, University of Florence/Italie (4 aut.); Division Geriatric Medicine, NEUROTEC, Karolinska Institutet, Stockholm Gerontology Research Center/Suède (5 aut.); Max-Planck Institute/Munich/Allemagne (6 aut.); Epidemiology, Demography, Biometry Program, National Institute on Aging/Bethesda, MD/Etats-Unis (8 aut.); Department of Epidemiology & Biostatistics, Erasmus Medical Center/Rotterdam/Pays-Bas (1 aut., 2 aut.); Epidemiology, Demography, Biometry Program, National Institute on Aging/Bethesda, Maryland/Etats-Unis (1 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Neurology; ISSN 0028-3878; Coden NEURAI; Etats-Unis; Da. 2000; Vol. 54; No. 11 SUP5; S24-S27; Bibl. 26 ref.</SO>
<LA>Anglais</LA>
<EA>Article abstract-Data are lacking on the prognosis (institutionalization and death) of PD cases identified in population-based studies. Data from five population-based European studies were compared and pooled. Each study used comparable two-step screening methods to identify cases and performed one or more follow-up examinations of their respective participants after defined periods of time. PD was classified on the basis of questionnaire and clinical data. The studies include 16,143 participants (252 with PD). The relative risk (RR) (95% CI) of death associated with PD was 2.3 (1.8 to 3.0). The risk for death in men with PD (RR 3.1 [2.1 to 4.4]) was higher than in women with PD (RR 1.8 [1.2 to 5.1]). The rate of institutionalization varied across studies, increased with age, and was considerably higher in PD cases compared to noncases. Women with PD had a fivefold higher risk to live in a care facility than did men with PD. These data on mortality and rate of institutionalization reflect the high burden of PD in the population.</EA>
<CC>002B17G</CC>
<FD>Parkinson maladie; Europe; Institution spécialisée; Mortalité; Etude comparative; Pronostic; Evolution; Epidémiologie; Personne âgée</FD>
<FG>Homme; Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative; Santé publique</FG>
<ED>Parkinson disease; Europe; Specialized institution; Mortality; Comparative study; Prognosis; Evolution; Epidemiology; Elderly</ED>
<EG>Human; Nervous system diseases; Central nervous system disease; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease; Public health</EG>
<SD>Parkinson enfermedad; Europa; Institución especializada; Mortalidad; Estudio comparativo; Pronóstico; Evolución; Epidemiología; Anciano</SD>
<LO>INIST-6345.354000088769070060</LO>
<ID>00-0326325</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001369 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 001369 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:00-0326325
   |texte=   Prognosis with Parkinson's disease in Europe : A collaborative study of population-based cohorts
}}

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024

	La maladie de Parkinson en France (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

La maladie de Parkinson en France (serveur d'exploration)

Prognosis with Parkinson's disease in Europe : A collaborative study of population-based cohorts

Prognosis with Parkinson's disease in Europe : A collaborative study of population-based cohorts

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri